A report detailed a case of belly dancer's dyskinesia after an acute corpus callosum infarction. (JAMA Neurology)
The Doomsday Clock showed strong negative associations with mortality specific to Alzheimer's disease and several mental health conditions. (Bulletin of the Atomic Sciences)
In a proof-of-concept study, spinal cord neuromodulation promoted robust activity during walking and cycling assisted by robotic devices. (Science Robotics)
Venture capital investment in neurology companies grew substantially in recent decades; the largest share was in pharmaceuticals and drug discovery. (JAMA Neurology)
The U.S. Preventive Services Task Force posted a draft research plan on screening for cognitive impairment in older adults, available for review and public comment through April 2.
The American Academy of Neurology, the American Epilepsy Society, and the Epilepsy Foundation of America issued a consensus position statement on seizures, driver's licenses, and medical reporting. (Neurology)
A new guideline from the American College of Physicians recommended combination therapy for acute episodic migraines. (Annals of Internal Medicine)
Antibody reactivity against Epstein-Barr virus nuclear antigen 1 and glial cellular adhesion molecule differentiated multiple sclerosis (MS) patients from healthy controls. (PNAS)
Exposure to nature induced analgesic effects by acting on nociception-related neural processing. (Nature Communications)
The FDA expanded the indication of eculizumab (Soliris) to include pediatric patients ages 6 and older with generalized myasthenia gravis who are anti-acetylcholine receptor antibody positive, the Muscular Dystrophy Association said.
Judy George covers neurology and neuroscience news for MedPage Today, writing about brain aging, Alzheimer’s, dementia, MS, rare diseases, epilepsy, autism, headache, stroke, Parkinson’s, ALS, concussion, CTE, sleep, pain, and more. Follow